None listed
Conditions
Brief summary
An initial evaluation of the Maya Renal Hypertension Ablation System for the treatment of subjects with chronic resistant hypertension
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
Subject has a systolic blood pressure greater than or equal to 160 mmHg Subject is on 2 or more anti hypertensive medications Bilateral Renal Arteries must be between 4-7mm diameter and greater than 20mm in length Subject signs informed consent and agrees to follow up visits
Exclusion criteria
Subject has a glomerular filtration rate (eGFR) of < 45mL/min/1.73m2, using the MDRD calculation. Subject has had a myocardial infarction, unstable angina pectoris, or a cerebrovascular accident within 6 months of the screening visit. Subject has history of bleeding diathesis or coagulopathy, Type 1 diabetes, renal artery stenosis, valve disease, planned surgery or intervention in coming 6 months, allergy to listed drugs in protocol, is pregnant, or has peripheral disease precluding a 9F sheath introducer.